Role of curcumin in modulating plasma PON1 arylesterase activity and susceptibility to LDL oxidation in oxidatively challenged wistar rats

Letters in Drug Design and Discovery

Volumn 12, Issue 4, 2015, Pages 319-323

  Singh, Prabhakar ^a   Rizvi, Syed Ibrahim ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Curcumin; LDL oxidation; Oxidative stress; Plasma; PON1; Thiol ( SH)

Indexed keywords

AMINO ACID; ARYLDIALKYLPHOSPHATASE 1; COPPER CHLORIDE; CURCUMIN; FREE RADICAL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CURCUMA LONGA; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME MODIFICATION; IN VIVO STUDY; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; TREATMENT DURATION;

EID: 84926472566     PISSN: 15701808     EISSN: 1875628X     Source Type: Journal    
DOI: 10.2174/1570180811666141016000539     Document Type: Article

References (32)

1. Durrington, P.N.; Mackness, B.; Mackness, M.I. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 473-480
2. Aviram, M.; Hardak, E.; Vaya, J.; Mahmood, S.; Milo, S.; Hoffman, A.; Billicke, S.; Draganov, D.; Rosenblat, M. Human serum paraoxonase (PON) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation, 2000, 101, 2510-2517
3. Reaven, P.D.; Napoli, C.; Merat, S.; Witztumc, J.L. Lipoprotein modification and atherosclerosis in aging. Exp. Gerontol., 1999, 34, 527-537
4. Yamagishi, S.; Matsui, T.; Nakamura, K.; Kawano, K.; Kitanoet, S. Circulating oxidized low-density lipoprotein (LDL) induces apoptosis and stimulates monocyte chemoattractant protein-1 expression in cultured endothelial cells. Lett. Drug. Des. Discov., 2006 3(8), 582-585
5. Tavori, H.; Aviram, M.; Khatib, S.; Musa, R.; Nitecki, S.; Hoffman, A.; Vaya, J. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic. Biol. Med., 2009, 46, 607-615
6. Mehdi, M.M.; Rizvi, S.I. Human Plasma Paraoxonase 1 Arylesterase Activity During Aging: Correlation with Susceptibility of LDL Oxidation. Arch. Med. Res., 2012, 43, 438-443
7. Shih, D.M.; Xia, Y.R.; Wang, X.P.; Miller, E.; Castellani, L.W.; Subbanagounder, G.; Cheroutre, H.; Faull, K.F.; Berliner, J.A.; Witztum, J.L.; Lusis, A.J. Combined serum paraoxonase knockout/ apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J. Biol. Chem., 2000, 275, 17527-17535
8. Valko, M.; Morris, H.; Cronin, M.T.D. Metal Toxicity and oxidative stress. Curr. Med. Chem., 2005, 12, 1161-1208
9. Kumar, D.; Singh, S.; Singh, A.K.; Rizvi, S.I. Pomegranate (Punica granatum) peel extract provides protection against mercuric chloride-induced oxidative stress in Wistar strain rats. Pharm. Biol., 2013, 51, 441-446
10. Salonen, J.T.; Seppänen, K.; Lakka, T.A.; Salonen, R.; Kaplan, G.A. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in Eastern Finland. Atherosclerosis, 2000, 148, 265-273
11. Singh, P.; Rizvi, S.I. Anti-Oxidative Effect of Curcumin Against Tert- Butyl Hydroperoxide Induced Oxidative Stress in the Human Erythrocytes. Nat. Prod. J., 2012, 2, 69-73
12. Singh, P.; Rizvi, S.I. Curcumin activates erythrocyte membrane acetylcholinesterase. Lett. Drug. Des. Discov., 2013, 10, 550-556
13. O'Connell, M.A.; Rushworth, S.A. Curcumin: potential for hepatic fibrosis therapy? Br. J. Pharmacol., 2008, 153, 403-405
14. Liu, Y.; Ye, M.; Wu, Q.; Wu, L.; Xu, J. Synthesis and Evaluation of 4-arylmethyl Curcumin Analgues as Potent Hsp90 Inhibitors. Lett. Drug. Des. Discov., 2014, 11(8), 993-999
15. Chen, X.; Ren, L.; Zhang, X.; Guo, L.; Zhou, J.; Liang, G.; Wang, Y. Improved Pharmacokinetic Profile and Anti-Inflammatory Property of a Novel Curcumin Derivative, A50. Lett. Drug. Des. Discov., 2013, 10(6), 535-542
16. Soudamini, K.K.; Unnikrishnan, M.C.; Soni, K.B. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J. Physiol. Pharmacol., 1992, 36, 239-243
17. Schrader, C.; Schiborr, C.; Frank, J.; Rimbach, G. Curcumin induces paraoxonase 1 in cultured hepatocytes in vitro but not in mouse liver in vivo. Brit. J. Nutr., 2011, 105, 167-170
18. Soni, K.B.; Kuttan, R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J. Physiol. Pharmacol., 1992, 36, 273-275
19. Marczylo, T.H.; Verschoyle, R.D.; Cooke, D.N.; Morazzoni, P.; Steward, W.P.; Gescher, A.J. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother. Pharmacol., 2007, 60, 171-177
20. Kitajima, H.; Yamaguchi, T.; Kimoto, E. Hemolysis of human erythrocytes under hydrostatic pressure is suppressed by crosslinking of membrane proteins. J. Biochem., 1990, 108, 1057-1062
21. Schnitzer, E.; Pinchuk, I.; Bor, A.; Fainaru, M.; Samuni, A.M.; Lichtenberg, D. Lipid oxidation in unfractionated serum and plasma. Chem. Phys. Lipids, 1998, 92, 151-170
22. Gencer, N.; Arslan, O. In vitro effects of some pesticides on PON1Q192 and PON1R192 isoenzymes from human serum. Fresen. Envir. Bull., 2011, 20, 590-596
23. Mueller, R.F.; Hornung, S.; Furlong, C.E.; Anderson, J.; Giblett, E.R.; Motulsky, A.G. Plasma Paraoxonase Polymorphism: A New Enzyme Assay, Population, Family, Biochemical, and Linkage Studies. Am. J. Hum. Genet., 1983, 35, 393-408
24. Costa, L.G.; Vitalone, A.; Cole, T.B.; Furlong, C.E. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol., 2005, 69, 541-550
25. Josse, D.; Bartels, C.; Lockridge, D.; Masson, P. PON1 structure. In: Costa LG, Furlong CE, editors. Paraoxonase (PON1) in health and disease: basic and clinical aspects. MA: Kluwer Academic Publishers, Norwell, 2002; pp. 27-52
26. Tavori, H.; Aviram, M.; Khatib, S.; Musa, R.; Mannheim. D.; Karmeli, R.; Vaya, J. Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284. Free Radic. Biol. Med., 2011, 50, 148-156
27. Rajković, M.G.; Rumora, L.; Juretić, D.; Grubisić, T.Z.; Flegar- Mestrić, Z.; Vrkić, N.; Sinjeri, Z.; Barisić, K. Effect of non-genetic factors on paraoxonase 1 activity in patients undergoing hemodialysis. Clin. Biochem., 2010, 43, 1375-1380
28. Jarvik, G.P.; Tsai, N.T.; Mc Kinstry, L.A.; Wani, R.; Brophy, V.H.; Richter, R.J.; Schellenberg, G.D.; Heagerty, P.J.; Hatsukami, T.S.; Furlong, C.E. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler. Thromb. Vasc. Biol., 2002, 22, 1329-1333
29. Aviram, M.; Rosenblat, M.; Billecke, S.; Erogul, J.; Sorenson, R.; Bisgaier, C.L.; Newton, R.S.; La Du, B. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med., 1999, 26, 892-904
30. Mahfouz, M.; Zhou, Q.; Kummerow, F.A. Effects of Curcumin on LDL Oxidation in vitro, and Lipid Peroxidation and Antioxidant Enzymes in Cholesterol fed Rabbits. Int. J. Vitam. Nutr. Res., 2011, 81, 278-291
31. Mehdi, M.M.; Rizvi, S.I. Plasma Protein Hydroperoxides During Aging in Humans: Correlation with Paraoxonase 1 (PON1) Arylesterase Activity and Plasma Total Thiols. Arch. Med. Res., 2013, 44, 136-141
32. Punithavathi, D.; Babu, M.; Arumugam, V.; Venkatesan, N. Bleomycin- Induced Oxidative Stress and Lung Injury in Rats: Inhibition by Curcumin. Lett. Drug. Des. Discov., 2006, 3(10), 714-722.